CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT

Kartick C Pramanik1, Neel M Fofaria, Parul Gupta

  • 1Corresponding Author: Sanjay K. Srivastava, Department of Biomedical Sciences, Suite 1103, Texas Tech University Health Sciences Center, 1406 Coulter Drive, Amarillo, TX 79106. sanjay.srivastava@ttuhsc.edu.

Insights

Capsaicin induces apoptosis in pancreatic cancer cells by activating the JNK/FOXO1 pathway, leading to BIM activation and tumor suppression in vivo. This research uncovers a novel mechanism for capsaicin

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Pancreatic cancer remains a significant health challenge with limited effective treatments.
  • Understanding the molecular mechanisms of novel therapeutic agents is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the mechanism by which capsaicin induces apoptosis in pancreatic cancer cells.
  • To elucidate the role of the JNK/FOXO1/BIM signaling pathway in capsaicin's anti-cancer effects.

Main Methods:

  • Capsaicin treatment of pancreatic cancer cell lines (BxPC-3, AsPC-1, L3.6PL).
  • Western blotting to assess protein phosphorylation and expression (JNK, FOXO1, BIM, caspase-3, PARP, CBP, SirT-1).
  • siRNA-mediated gene silencing and overexpression studies.
  • In vivo xenograft studies in athymic nude mice.

Main Results:

  • Capsaicin treatment activated JNK, FOXO1, and BIM, leading to apoptosis via caspase-3 and PARP cleavage.
  • Capsaicin increased FOXO1 nuclear expression and acetylation, dependent on CBP and SirT-1.
  • Inhibition or silencing of JNK, FOXO1, or BIM attenuated capsaicin-induced apoptosis.
  • Capsaicin suppressed pancreatic tumor xenograft growth in mice.

Conclusions:

  • Capsaicin triggers apoptosis in pancreatic cancer cells through JNK/FOXO1 pathway activation and subsequent BIM induction.
  • FOXO1 acetylation, modulated by CBP and SirT-1, is critical for capsaicin's pro-apoptotic effects.
  • Capsaicin demonstrates therapeutic potential against pancreatic cancer, warranting further investigation.